SCOPUS 정보 검색 플랫폼

Current Opinion in Pharmacology

Volumn 10, Issue 4, 2010, Pages 353-355

Factors influencing development of new therapeutics for oncology

(2) Winquist, Raymond J a Boucher, Diane M a

a VERTEX PHARMACEUTICALS (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOLOGY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER SCREENING; CANCER STEM CELL; CELL FUNCTION; DRUG EFFICACY; DRUG RESEARCH; EDITORIAL; HIGH THROUGHPUT SCREENING; HOMEOSTASIS; IMMUNE RESPONSE; ONCOLOGY; OXIDATION REDUCTION REACTION; PHARMACODYNAMICS; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOMEDICAL RESEARCH; CELL LINE, TUMOR; DRUG DISCOVERY; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; OXIDATION-REDUCTION;

EID: 77955269381 PISSN: 14714892 EISSN: None Source Type: Journal
DOI: 10.1016/j.coph.2010.06.011 Document Type: Editorial

Times cited : (1)

References (8)

1
- 77955271031
- At a crossroads in oncology
- Kamb A. At a crossroads in oncology. Curr Opin Pharmacol 2010, 10:356-361.
- (2010) Curr Opin Pharmacol , vol.10 , pp. 356-361
- Kamb, A.¹

2
- 77955274524
- Redox metabolism and malignancy
- Grek C., Tew K. Redox metabolism and malignancy. Curr Opin Pharmacol 2010, 10:362-368.
- (2010) Curr Opin Pharmacol , vol.10 , pp. 362-368
- Grek, C.¹ Tew, K.²

3
- 77955274176
- Tumor-stromal cell interactions and opportunities for therapeutic intervention
- Udagawa T., Wood M. Tumor-stromal cell interactions and opportunities for therapeutic intervention. Curr Opin Pharmacol 2010, 10:369-374.
- (2010) Curr Opin Pharmacol , vol.10 , pp. 369-374
- Udagawa, T.¹ Wood, M.²

4
- 77955275498
- Efficacy of anti-cancer agents in cell lines vs human primary tumor tissue
- Cree I., Glaysher S., Harvey A.L. Efficacy of anti-cancer agents in cell lines vs human primary tumor tissue. Curr Opin Pharmacol 2010, 10:375-379.
- (2010) Curr Opin Pharmacol , vol.10 , pp. 375-379
- Cree, I.¹ Glaysher, S.² Harvey, A.L.³

5
- 77955268969
- New models for cancer research: human cancer stem cell xenografts
- Baiocchi M., Biffoni M., Ricci-Vitiani L., Pilozzi E., deMaria R. New models for cancer research: human cancer stem cell xenografts. Curr Opin Pharmacol 2010, 10:380-384.
- (2010) Curr Opin Pharmacol , vol.10 , pp. 380-384
- Baiocchi, M.¹ Biffoni, M.² Ricci-Vitiani, L.³ Pilozzi, E.⁴ deMaria, R.⁵

6
- 77955278329
- Cancer stem cells as the relevant biomass for drug discovery
- Winquist R., Furey B.F., Boucher D.M. Cancer stem cells as the relevant biomass for drug discovery. Curr Opin Pharmacol 2010, 10:385-390.
- (2010) Curr Opin Pharmacol , vol.10 , pp. 385-390
- Winquist, R.¹ Furey, B.F.² Boucher, D.M.³

7
- 77955274583
- The challenge of selecting the " right" in vivo oncology pharmacology model
- Firestone B. The challenge of selecting the " right" in vivo oncology pharmacology model. Curr Opin Pharmacol 2010, 10:391-396.
- (2010) Curr Opin Pharmacol , vol.10 , pp. 391-396
- Firestone, B.¹

8
- 77955269720
- Combinations of PARP, Hedgehog and HDAC inhibitors with standard drugs
- Teicher B. Combinations of PARP, Hedgehog and HDAC inhibitors with standard drugs. Curr Opin Pharmacol 2010, 10:397-404.
- (2010) Curr Opin Pharmacol , vol.10 , pp. 397-404
- Teicher, B.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.